New Imaging Techniques for Non-Alcoholic Steatohepatitis

Clinics in Liver Disease

Volumn 13, Issue 4, 2009, Pages 607-619

  Browning, Jeffrey D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Computed tomography; Fatty liver; Magnetic resonance; Steatohepatitis; Ultrasound

Indexed keywords

ALBUMIN; CONTRAST MEDIUM; ECHOVIST; FLUOROCARBON; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOXETIC ACID; GALACTOSE; LIPID; NITROGEN; POLYMER;

CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ELASTOGRAPHY; HEPATITIS; HUMAN; KUPFFER CELL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; METABOLIC SYNDROME X; MICROBUBBLE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; REVIEW; SCREENING TEST;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATTY LIVER; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ULTRASONOGRAPHY;

EID: 70349776194     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2009.07.002     Document Type: Review

References (59)

1. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 7 (1980) 434-438
2. Day C.P., and James O.F.W. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 4 (1998) 842-845
3. Wanless I.R., and Shiota K. The pathogenesis of non-alcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 24 1 (2004) 99-106
4. Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37 6 (2003) 1286-1292
5. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 6 (2004) 1387-1395
6. Weston S.R., Leyden W., Murphy R., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41 2 (2005) 372-379
7. Szczepaniak L.S., Leonard D., Browning J.D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468 [Epub 2004]
8. Lonardo A., Bellini M., Tondelli E., et al. Nonalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded?. Am J Gastroenterol 90 11 (1995) 2072-2074
9. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiologic imaging in nonalcoholic fatty liver disease. Gastroenterology 123 3 (2002) 745-750
10. Longo R., Ricci C., Masutti F., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 4 (1993) 297-302
11. Gosink B.B., Lemon S.K., Scheible W., et al. Accuracy of ultrasonography in diagnosis of hepatocellular disease. AJR Am J Roentgenol 133 1 (1979) 19-23
12. Foster K.J., Dewbury K.C., Griffith A.H., et al. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 53 629 (1980) 440-442
13. Debongnie J.C., Pauls C., Fievez M., et al. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 22 2 (1981) 130-135
14. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292 (1986) 13-15
15. Joseph A.E., Saverymuttu S.H., al-Sam S., et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43 (1991) 26-31
16. Mihmanli I., Kantarci F., Yilmaz M.H., et al. Effect of diffuse fatty infiltration of the liver on hepatic artery resistance index. J Clin Ultrasound 33 3 (2005) 95-99
17. Oguzkurt L., Yildirim T., Torun D., et al. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 54 2 (2005) 253-257
18. Balci A., Karazincir S., Sumbas H., et al. Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics. J Clin Ultrasound 36 3 (2008) 134-140
19. Erdogmus B., Tamer A., Buyukkaya R., et al. Portal vein hemodynamics in patients with nonalcoholic fatty liver disease. Tohoku J Exp Med 215 1 (2008) 89-93
20. Uzun H., Yazici B., Erdogmus B., et al. Doppler waveforms of the hepatic veins in children with diffuse fatty infiltration of the liver. Eur J Radiol (2008) [Epub ahead of print]
21. Dietrich C.F., Lee J.H., Gottschalk R., et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol 171 2 (1998) 437-443
22. Magalotti D., Marchesini G., Ramilli S., et al. Splanchnic haemodynamics in nonalcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot study. Dig Liver Dis 36 6 (2004) 406-411
23. Seifalian A.M., Chidambaram V., Rolles K., et al. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 4 1 (1998) 71-77
24. Lim A.K., Patel N., Eckersley R.J., et al. Can Doppler sonography grade the severity of hepatitis C-related liver disease?. AJR Am J Roentgenol 184 6 (2005) 1848-1853
25. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 1 (2005) 48-54
26. Marcellin P., Ziol M., Bedossa P., et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29 2 (2009) 242-247 [Epub 2008 Jul 9]
27. Corpechot C., El Naggar A., Poujol-Robert A., et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43 5 (2006) 1118-1124
28. Nahon P., Kettaneh A., Tengher-Barna I., et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J. Hepatol 49 6 (2008) 1062-1068 [Epub 2008 Oct 7]
29. Yoneda M., Mawatari H., Fujita K., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 40 5 (2008) 371-378 [Epub 2007 Dec 20]
30. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 3 (2004) 527-532
31. Moriyasu F., Iijima H., Tsuchiya K., et al. Diagnosis of NASH using delayed parenchymal imaging of contrast ultrasound. Hepatol Res 33 (2005) 97-99
32. Iijima H., Moriyasu F., Tsuchiya K., et al. Decrease in accumulation of ultrasound contrast microbubbles in nonalcoholic steatohepatitis. Hepatol Res 37 (2007) 722-730
33. Mendler M.H., Bouillet P., Le Sidaner A., et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28 5 (1998) 785-794
34. Jacobs J.E., Birnbaum B.A., Shapiro M.A., et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR Am J Roentgenol 171 3 (1998) 659-664
35. Partanen K.P. Dynamic CT of liver cirrhosis. Invest Radiol 19 4 (1984) 303-308
36. Miles K.A., Hayball M.P., and Dixon A.K. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188 2 (1993) 405-411
37. Blomley M.J., Coulden R., Dawson P., et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19 3 (1995) 424-433
38. Tsushima Y., Blomley J.K., Kusano S., et al. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 44 8 (1999) 1632-1638
39. Van Beers B.E., Leconte I., Materne R., et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176 3 (2001) 667-673
40. Hashimoto K., Murakami T., Dono K., et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep 16 4 (2006) 677-683
41. Miles K.A., and Griffiths M.R. Perfusion CT: a worthwhile enhancement?. Br J Radiol 76 (2003) 220-231
42. Kobayashi M., Suzuki M., Ikeda H., et al. Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol Res 39 1 (2009) 31-39 [Epub 2008 Aug 28]
43. Mazhar S.M., Shiehmorteza M., and Sirlin C.B. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 7 2 (2009) 135-140 [Epub 2008 Dec 6]
44. Bonekamp S., Kamel I., Solga S., et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol 50 1 (2009) 17-35 [Epub 2008 Nov 8]
45. Tanimoto A., Yuasa Y., Shinmoto H., et al. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222 3 (2002) 661-666
46. Lucidarme O., Baleston F., Cadi M., et al. Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique?. Eur Radiol 13 3 (2003) 467-474 [Epub 2002 Sep 13]
47. Tanimoto A., Mukai M., and Kuribayashi S. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters. Magn Reson Med Sci 5 2 (2006) 89-98
48. Tomita K., Tanimoto A., Irie R., et al. Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 28 6 (2008) 1444-1450
49. Tsuda N., Okada M., and Murakami T. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol (2008). Doi:10.1016/j.ejrad.2008.1009.1036
50. Boutry S., Burtea C., Laurent S., et al. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn Reson Med 53 4 (2005) 800-807
51. Longo R., Pollesello P., Ricci C., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 3 (1995) 281-285
52. Szczepaniak L.S., Babcock E.E., Schick F., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276 5 Pt 1 (1999) E977-E989
53. Corbin I.R., Furth E.E., Pickup S., et al. In vivo assessment of hepatic triglycerides in murine nonalcoholic fatty liver disease using magnetic resonance spectroscopy. Biochim Biophys Acta (2009). Doi:10.1016/j.bbalip.2009.02.014
54. Puri P., Baillie R.A., Wiest M.M., et al. A lipidomic analysis of non-alcoholic fatty liver disease. Hepatology 46 4 (2007) 1081-1090
55. Khan S.A., Cox I.J., Hamilton G., et al. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int 25 2 (2005) 273-281
56. Noren B., Dahlqvist O., Lundberg P., et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur J Radiol 66 2 (2008) 313-320 [Epub 2007 Jul 23]
57. Cortez-Pinto H., Chatham J., Chacko V.P., et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282 17 (1999) 1659-1664
58. Solga S.F., Horska A., Hemker S., et al. Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. Liver Int 28 5 (2008) 675-681 [Epub 2008 Mar 4]
59. Sherry A.D., and Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 10 (2008) 391-411